Biggest News Aggregation in the World
📰 Nasdaq Huma News

Page 3 - Nasdaq Huma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Huma. Real-time updates on events, politics, business and more.

Humacyte (NASDAQ:HUMA) Raised to Neutral at Piper Sandler

Piper Sandler upgraded shares of Humacyte (NASDAQ:HUMA – Free Report) from an underweight rating to a neutral rating in a research note issued to investors on Monday, Marketbeat reports. The brokerage currently has $3.50 price objective on the stock, up from their previous price objective of $2.75. Separately, Cantor Fitzgerald initiated coverage on Humacyte in […]
Hong Kong Laurae Niklason Piper Sandler Cantor Fitzgerald United Asset Strategies Inc Y Intercept Hong Kong Ltd

Comparing Kymera Therapeutics (NASDAQ:KYMR) & Humacyte (NASDAQ:HUMA)

Humacyte (NASDAQ:HUMA – Get Free Report) and Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation. Profitability This table compares Humacyte and Kymera Therapeutics’ […]
United States North Carolina Kymera Therapeutics Inc Humacyte Inc Get Free Report Kymera Therapeutics
Source: wkrb13.com

Humacyte (NASDAQ:HUMA) Research Coverage Started at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Humacyte (NASDAQ:HUMA – Get Rating) in a report published on Thursday, The Fly reports. The brokerage issued an overweight rating and a $6.00 target price on the stock. Separately, Benchmark reissued a buy rating and issued a $16.00 price objective on shares of Humacyte in a research report […]
Hong Kong Laurae Niklason Heather Ledbetter Prichard Securities Exchange Commission Raymond James Associates Humacyte Inc
Source: wkrb13.com

Humacyte, Inc. (NASDAQ:HUMA) CEO Sells $1,560,000.00 in Stock

Humacyte, Inc. (NASDAQ:HUMA – Get Rating) CEO Laura E. Niklason sold 500,000 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $3.12, for a total transaction of $1,560,000.00. Following the transaction, the chief executive officer now directly owns 9,990,736 shares in the company, […]
Laurae Niklason Humacyte Inc Geode Capital Management Blackrock Inc Vanguard Group Inc Charles Schwab Investment Management Inc

Humacyte, Inc. (NASDAQ:HUMA) Sees Large Increase in Short Interest

Humacyte, Inc. (NASDAQ:HUMA – Get Rating) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 5,520,000 shares, an increase of 5.7% from the April 30th total of 5,220,000 shares. Based on an average daily volume of 262,600 shares, the days-to-cover ratio is presently […]
United States Heather Ledbetter Prichard Laurae Niklason Proshare Advisors American International Group Inc Humacyte Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 2,625,000 Shares

Humacyte, Inc. (NASDAQ:HUMA – Get Rating) CEO Laura E. Niklason sold 2,625,000 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $2.75, for a total transaction of $7,218,750.00. Following the completion of the sale, the chief executive officer now directly owns […]
Laurae Niklason Swiss National Bank York Mellon Corp Humacyte Inc Advisor Group Holdings Inc Citigroup Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science